IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Oct 2023 (Vol: 2023, Issue: 10)

Next Issue >>

Download pdf of entire issue

Section: Distribution & Marketing
GSK Partners with Zhifei to Boost Shingrix® in China Published: 25 Oct-2023
By: Shweta Gupta
Abstract Fulltext:
Section: Licensing
Genentech Pays Orionis US$47 M Upfront for Molecular Glue Medicines Published: 7 Oct-2023
By: Lucy Haggerty
Abstract Fulltext:
Roche Partners with Ionis for RNA-Targeting Neurology Programmes Published: 10 Oct-2023
By: Lucy Haggerty
Abstract Fulltext:
GSK Signs US$1.5 B ADC Licensing Pact with Hansoh Pharma Published: 27 Oct-2023
By: Lalit Mishra
Abstract Fulltext:
Section: Mergers & Acquisitions
Bristol Myers Squibb to Acquire Mirati Therapeutics for Up to US$5.8 B Published: 12 Oct-2023
By: Lucy Haggerty
Abstract Fulltext:
Eli Lilly to Acquire Point Biopharma to Strengthen its Oncology Portfolio Published: 14 Oct-2023
By: Shweta Gupta
Abstract Fulltext:
Kyowa Kirin to Acquire Orchard Therapeutics for US$477.6 M Published: 14 Oct-2023
By: Ayush Saxena
Abstract Fulltext:
Alfasigma to Acquire Intercept Pharmaceuticals to Expand into Liver Diseases Published: 18 Oct-2023
By: Amit Kaushik
Abstract Fulltext:
Novo Nordisk to Acquire Ocedurenone for Hypertension from KBP Biosciences Published: 25 Oct-2023
By: Lalit Mishra
Abstract Fulltext:
Roche Pays US$7.1 B for Bowel Disease Drug from Roivant and Pfizer Published: 27 Oct-2023
By: Lucy Haggerty
Abstract Fulltext:
Section: Opinion & Analysis
IQVIA Pharma Deals Half-Year Review of 2023 Published: 7 Oct-2023
By: Lucy Haggerty,Swati Sharan & Taskin Ahmed
Abstract Fulltext:
Section: Research & Development
Sanofi and Teva to Collaborate on Inflammatory Bowel Disease Treatment Published: 13 Oct-2023
By: Lalit Mishra
Abstract Fulltext:
Roche Signs US$2 B Partnership with Monte Rosa for Molecular Glue Medicines Published: 30 Oct-2023
By: Amit Kaushik
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in